Your preferences have been updated successfully.
Top 30 Lists
Novartis, Atlas Ventures Back Upstart IFM Therapeutics In $27M Raise
<span style="line-height: 20.8px;">Atlas-incubated startup IFM Therapeutics has raised $27 million in a Series A round as it looks to begin clinical stage trials against cancer and inflammatory diseases.</span>
READ FULL INVESTMENT ARTICLE
In this article